Evaluation of a UCMK/dCK fusion enzyme for gemcitabine-mediated cytotoxicity.

about

Evaluation of a UCMK/dCK fusion enzyme for gemcitabine-mediated cytotoxicity.

Item

http://www.wikidata.org/entity/Q35613655

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Evaluation of a UCMK/dCK fusion enzyme for gemcitabine-mediated cytotoxicity.

@ast

Evaluation of a UCMK/dCK fusion enzyme for gemcitabine-mediated cytotoxicity.

@en

type

Item

label

Evaluation of a UCMK/dCK fusion enzyme for gemcitabine-mediated cytotoxicity.

@ast

Evaluation of a UCMK/dCK fusion enzyme for gemcitabine-mediated cytotoxicity.

@en

prefLabel

Evaluation of a UCMK/dCK fusion enzyme for gemcitabine-mediated cytotoxicity.

@ast

Evaluation of a UCMK/dCK fusion enzyme for gemcitabine-mediated cytotoxicity.

@en

P1476

Evaluation of a UCMK/dCK fusion enzyme for gemcitabine-mediated cytotoxicity.

@en

P2093

Adam J Johnson

http://www.w3.org/2001/XMLSchema#string

Margaret E Black

http://www.w3.org/2001/XMLSchema#string

Melissa N Brown

http://www.w3.org/2001/XMLSchema#string

P2860

Phosphorylation of deoxycytidine analog monophosphates by UMP-CMP kinase: molecular characterization of the human enzyme

Structure of human dCK suggests strategies to improve anticancer and antiviral therapy

Cloning, characterization, and modeling of mouse and human guanylate kinases

Gemcitabine-based chemogene therapy for pancreatic cancer using Ad-dCK::UMK GDEPT and TS/RR siRNA strategies

Potentiating AZT activation: structures of wild-type and mutant human thymidylate kinase suggest reasons for the mutants' improved kinetics with the HIV prodrug metabolite AZTMP

Characterization of human UMP/CMP kinase and its phosphorylation of D- and L-form deoxycytidine analogue monophosphates

Reaction of human UMP-CMP kinase with natural and analog substrates

Transfection of wild-type deoxycytidine kinase (dck) cDNA into an AraC- and DAC-resistant rat leukemic cell line of clonal origin fully restores drug sensitivity

Physiological concentrations of purines and pyrimidines

Phase III trial of gemcitabine plus cisplatin versus cisplatin alone in patients with locally advanced or metastatic non-small-cell lung cancer.

P304

199-204

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.BBRC.2011.11.025

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

1-2

http://www.w3.org/2001/XMLSchema#string

P478

416

http://www.w3.org/2001/XMLSchema#string

P577

2011-11-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51810591

http://www.w3.org/2001/XMLSchema#string

P698

22093835

http://www.w3.org/2001/XMLSchema#string

P932

3237957

http://www.w3.org/2001/XMLSchema#string